🌍 The global pharmaceutical pricing experts

Turn complex pricing challenges into competitive advantage

Book a no-commitment consultation with GPI's pharmaceutical pricing specialists. We'll listen to your challenges first, then show you exactly how our curated data, technology, and expert guidance can help.

100+ markets covered — validated list prices, net pricing, rebates, and market access outcomes

Technology-enabled analytics — real-time IRP simulations, competitive tracking, and scenario modelling

Senior pricing expertise — specialists who have guided successful launches across HTA-led, IRP-driven, and hybrid markets

No obligation — we'll understand your needs first and propose next steps that make sense for you

Book your consultation

Choose how you'd like to connect

Pick a time in the calendar, or if nothing suits, leave your details and we'll arrange a time that works for you.

Book a time

Pick a slot that works for you

Select a time below to speak with a GPI specialist. We'll start with your challenges and show you exactly how we can help — no obligation.

No commitment required — 30–45 minutes, tailored to your therapy area.
Most teams book 2–3 weeks out, so the sooner you reach out the better.

Send a message

Can't find a suitable time?

Leave your details below and a member of our team will be in touch to arrange something that works for you.

Trusted by leading pharmaceutical companies worldwide

Pfizer
AstraZeneca
Novo Nordisk
Moderna
Jazz Pharmaceuticals
Clarivate
What we do

Three ways GPI delivers your pharmaceutical pricing advantage

Curated data, enabled by technology, guided by specialist expertise. Our three service lines work independently or together — depending on where your challenges lie.

Data Intelligence

Access comprehensive pharmaceutical pricing intelligence across 100+ global markets. Our proprietary datasets combine list prices, net pricing, rebates, and market access outcomes — including regulatory intelligence for IRA, MFN, and JCA requirements you won't find anywhere else.

Explore Data Intelligence →

Technology Solutions

Turn weeks of analysis into hours. Our technology platforms — GPI Pulse and GPI Horizon — combine real-time pricing intelligence with scenario modelling and structured value assessment, delivering instant IRP simulations, competitive tracking, and automated reporting tailored to your workflow.

Our technology products

GPI Pulse — real-time pricing intelligence across 100+ markets with IRP simulation, competitive tracking, and scenario modelling

Horizon — self-service early pricing and value strategy platform for generating evidence-based price corridors before payer research begins

Explore Technology Solutions →

Strategic Advisory

Navigate complex pricing and market access challenges with the support of proven pharmaceutical pricing experts. Our senior consultants have guided successful launches across HTA-led, IRP-driven, and hybrid markets — from early-stage valuation to lifecycle management.

Explore Strategic Advisory →
Who we work with

Designed for how pharmaceutical teams actually work

From global leadership to local affiliate teams — GPI's solutions are built around the decisions that matter most at each level.

Enterprise & mid-market pharmaceutical

Global oversight, IRP governance, launch sequencing, and enterprise-wide policy compliance — at scale.

Biotechnology companies

Early pricing strategy, HTA preparation, and market access intelligence for assets moving through development into launch.

Clinical research organisations

Reimbursement landscape analysis, comparator identification, and pricing context for feasibility and study design.

Financial institutions

Portfolio-level pricing risk analysis, patent cliff modelling, and commercial due diligence support for investment decisions.

Regional & functional leads

Regional alignment, HTA strategies, budget impact analysis, and cross-market coordination without the complexity.

Local & affiliate teams

Local data accuracy, contracting and tender intelligence, and submission support workflows — built for in-market teams.

100+ Global markets with validated pricing intelligence
200+ Combined years of pharmaceutical pricing expertise across the GPI team
Top 10 Global pharma companies trust GPI's data and expertise
Client testimonials

Why leading pharmaceutical companies choose GPI

"GPI is always ready to listen, flexible, available and amenable to all business needs. Pfizer relies heavily on GPI's cost of treatment calculations in order to determine which products we have to report on, and therefore upholding our reputation."
Pfizer
Michelle Pardo Pricing Manager, Pfizer Inc.
"My experience with GPI is overall very good. GPI Pulse provides detailed information about pricing and reimbursement landscape… In studies where we need to classify countries based on reimbursement status, GPI is an essential source."
Fortrea
Global Feasibility Lead Fortrea
"Major impact. As GPI is our only price database provider, we fully trust them… We've been working together for a while and GPI has always met our expectations and solved our problems if any."
LFB
Marc Gauthier-Darnis Global Market Access Director, LFB
Common questions

Everything you need to know before your call

If your question isn't answered here, just ask us when we speak.

Ready to get started?

Talk to a specialist. No commitment.

We'll cover your pricing challenges and show you exactly how GPI can help.

100+ markets covered across our intelligence platform
170+ years of combined market access experience
Top 10 global pharma companies trust GPI
Book your consultation →

What does a GPI consultation cover?

+
A GPI consultation is tailored to you. We typically start by understanding your current pricing or market access challenges, then walk through how our curated data, GPI Pulse technology platform, or specialist advisory services could help — and agree clear next steps. There's no obligation and no sales pressure.

What services does GPI offer?

+
GPI offers three core service lines: Data Intelligence (curated pharmaceutical pricing and market access data across 100+ markets), Technology Solutions (IRP simulations, scenario modelling, and real-time pricing intelligence via GPI Pulse and GPI Horizon), and Strategic Advisory (senior consulting expertise across the full pharmaceutical pricing and market access lifecycle). These can be engaged independently or as an integrated solution.

Who does GPI work with?

+
GPI works with enterprise, mid-market, and emerging pharmaceutical companies, biotechnology firms, clinical research organisations, financial institutions, and professional services firms. Our clients include Pfizer, AstraZeneca, Moderna, Jazz Pharmaceuticals, and Clarivate — as well as specialist biotechs and CROs at earlier stages of development.

What markets does GPI cover?

+
GPI provides validated pricing and market access intelligence across 100+ global markets. We have particular depth in the EU5 (Germany, France, Italy, Spain, and the UK) and the United States, with strong coverage across APAC, the GCC, and the Nordics. Our data includes list prices, net pricing, rebates, and regulatory intelligence for IRA, MFN, and JCA requirements.

Is there a commitment required to book a consultation?

+
None at all. A GPI consultation is exploratory. We want to understand your challenges first, and then discuss whether and how we can help. If there's a fit, we'll be straightforward about what that looks like. If there isn't, we'll tell you that too.

How is GPI different from other pharmaceutical pricing data providers?

+
GPI sits at the intersection of curated data, technology, and specialist human expertise — combining all three in a way that most providers don't. Our data is proprietary and goes deeper than publicly available sources, our technology makes it immediately actionable, and our consulting team brings the experience to turn data into strategy. We're pharmaceutical pricing specialists — it's all we do.
Can't find a suitable time in our calendar?

Submit your details below and a member of our team will be in touch.